Mark Dumenil was born in London and moved to France in 1981 and directing his career towards supporting the introduction across Europe of innovative medical devices technology that make a difference to patients’ lives.
With nearly 30 years’ experience in a variety of international leadership roles at CR Bard Inc. Johnson and Johnson Inc. and CMA Microdialysis AB, Mark has developed a strong network of leading clinical, regulatory and well as market access specialists across Europe.
In 1996 Mark joined the Ethicon Division of J&J and was offered a leadership role in developing a new surgical oncology business. This was later merged with urology where he was made Vice President Europe for Oncology and Urology.
Today Mark leads an international healthcare consultancy based in Paris and London with consultants as well in Hamburg, Barcelona and Lund dedicated to introducing successfully promising medical technologies across Europe and he lives between France and the UK.